HomeInsightsPE

Beryl Drugs Ltd PE Ratio

Beryl Drugs Ltd PE Ratio

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Dec 12, 2024)

stocks purchased

33.0 K

Stocks Traded

(Dec 12, 2024)

Last Updated on: Dec 12, 2024

Image

Beryl Drugs Ltd

NSE: BERYLDRUGS

PE

57.9

Last updated on: Dec 12, 2024

Key Highlights

  • The P/E Ratio of Beryl Drugs Ltd is 57.9 as of 12 Dec 9.00 AM .
  • The P/E Ratio of Beryl Drugs Ltd changed from 7.2 on March 2019 to 19.4 on March 2024 . This represents a CAGR of 17.96% over 6 years.
  • The Latest Trading Price of Beryl Drugs Ltd is ₹ 38.8 as of 12 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Beryl Drugs Ltd

No data available

Company Fundamentals for Beryl Drugs Ltd

No data available

Image

Beryl Drugs Ltd

NSE: BERYLDRUGS

Share Price

₹ 38.8

3.38 (9.54%)

stock direction

Last updated on: Dec 12, 2024

Market Price of Beryl Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Beryl Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Dec 202438.8
11 Dec 202435.42
10 Dec 202434.37
09 Dec 202435.16
06 Dec 202434.16
05 Dec 202433.44
04 Dec 202433.62
03 Dec 202434.37
02 Dec 202433.58
29 Nov 202434.29

BlinkX Score for Beryl Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Beryl Drugs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Beryl Drugs Ltd5719
Sun Pharmaceuticals Industries Ltd384,32,948
Divis Laboratories Ltd861,57,873
Cipla Ltd251,16,809
Torrent Pharmaceuticals Ltd641,12,638
Mankind Pharma Ltd501,06,198

Key Valuation Metric of Beryl Drugs Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Beryl Drugs Ltd

No data available

* All values are in crore

Historical Revenue of Beryl Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Beryl Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Beryl Drugs Ltd

No data available

* All values are in crore

Historical Dividend Payout of Beryl Drugs Ltd

No data available

* All values are in %

About Beryl Drugs Ltd

  • Beryl Drugs Limited, based in Indore, was incorporated on August 24, 1993.
  • The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993.
  • The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange. The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally.
  • It offers I.V.fluids, and a range of small and large volume injectables.
  • It provides a range of eye/ear drops, veterinary products, and injections.

Beryl Drugs Ltd News Hub

News

Beryl Drugs standalone net profit declines 30.19% in the June 2024 quarter

Net profit of Beryl Drugs declined 30.19% to Rs 0.37 crore in the quarter ended June 2024 ...

Read more

2024-08-09 00:00:00

News

Beryl Drugs to conduct board meeting

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 3 September 20...

Read more

2024-08-27 00:00:00

News

Beryl Drugs to hold AGM

Beryl Drugs announced that the Annual General Meeting (AGM) of the company will be held on...

Read more

2024-09-11 00:00:00

News

Beryl Drugs to convene AGM

Beryl Drugs announced that the Annual General Meeting (AGM) of the company will be held on...

Read more

2024-09-11 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Beryl Drugs Ltd

What is the current PE Ratio of Beryl Drugs Ltd?

The Current PE Ratio of Beryl Drugs Ltd is 57.91 as on 12 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 12 Dec 2024.

What was the PE Ratio of Beryl Drugs Ltd last year?

The PE Ratio of Beryl Drugs Ltd was 8.11 last year, now the PE ratio is 57.91, showing a year-on-year growth of 614.1%.

What does the PE Ratio of Beryl Drugs Ltd indicate about its stock?

The PE Ratio of Beryl Drugs Ltd is 57.91. This ratio indicates that investors are willing to pay 57.91 times the earnings per share for each share of Beryl Drugs Ltd.

What is the PE Ratio Growth of Beryl Drugs Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Beryl Drugs Ltd grew by 614.1% whereas, the EPS ratio grew by -98.6.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions